Obesity Treatment Market Overview
The Obesity Treatment Market Size was valued at USD 12.6
billion in 2023. The Obesity Treatment market industry is projected to grow
from USD 14.71 Billion in 2024 to USD 32.3 billion by 2032, exhibiting a compound
annual growth rate (CAGR) of 10.32 % during the forecast period (2024 - 2032).
The obesity
treatment market continues its upward trajectory, driven by rising
global obesity rates and increasing awareness of related health risks. With
lifestyle changes and dietary habits contributing to the obesity epidemic,
pharmaceutical companies are developing innovative drugs targeting weight
management. Additionally, technological advancements in bariatric surgery and
minimally invasive procedures are reshaping treatment options. The market
witnesses a surge in demand for prescription medications, surgical interventions,
and minimally invasive devices. Moreover, collaborations between healthcare
providers, research institutions, and pharmaceutical companies are fostering
research and development activities, further propelling market growth. However,
challenges like reimbursement issues and regulatory hurdles persist,
influencing market dynamics.
The Obesity Treatment Market continues to witness
substantial growth driven by the increasing prevalence of obesity worldwide.
With a surge in lifestyle-related disorders, the demand for effective obesity
treatments has intensified. Key players in the market are innovating across
various modalities including weight loss surgery, prescription obesity drugs,
weight loss and bariatric surgery, and dietary interventions for obesity.
Weight loss surgery, a pivotal aspect of obesity treatment,
has garnered significant attention due to its efficacy in promoting weight
reduction and improving metabolic health. Procedures like gastric bypass and
sleeve gastrectomy offer tangible results for patients struggling with severe
obesity.
In tandem with surgical interventions, prescription obesity
drugs have emerged as a complementary approach to manage weight and mitigate
associated health risks. These drugs target appetite regulation, fat
absorption, and metabolism to aid in weight loss.
Furthermore, the integration of weight loss and bariatric
surgery provides comprehensive solutions for patients seeking long-term weight
management and metabolic health improvement.
Dietary
interventions for obesity play a fundamental role in both prevention
and treatment strategies. Lifestyle modifications, dietary counseling, and
personalized nutrition plans contribute significantly to sustainable weight
loss and overall well-being.
As the obesity epidemic persists, stakeholders in the
Obesity Treatment Market are poised to address evolving patient needs through
innovative therapies and comprehensive care models, fostering a paradigm shift
towards effective obesity management.
Obesity Treatment Market Segmentation
The global obesity treatment market has been studied by MRFR
on the basis of a type, diagnosis, treatment, and end-user. These segments and
data in them are expected to facilitate the decision-making process for the
future.
By type, the obesity treatment market has been studied on
the basis of food obesity, anxiety obesity, inactivity obesity, atherogenic
obesity, venous obesity, and gluten obesity.
By diagnosis, the report containing details of the treatment
for obesity market has been segmented into physical examination, blood tests,
and others. The blood tests segment includes thyroid test, liver function test,
cholesterol test, and others. The physical examination segment comprises blood
pressure measurement, heart rate measurement, and others.
By treatment, the study on the global obesity treatment
market includes surgery, medication, lifestyle changes, and others. The
medication segment has been studied on the basis of lorcaserin, orlistat,
liraglutide, phentermine and topiramate, and others. The surgery segment
includes Laparoscopic Adjustable Gastric Banding (LAGB), gastric bypass
surgery, biliopancreatic diversion, gastric sleeve, gastric sleeve, and
others.
By end-user, the report on the obesity treatment market
includes clinics, pharmacies, hospitals, and others.
Obesity Treatment Market Competitive Landscape
The obesity
treatment companies are Arena Pharmaceuticals, Inc. (U.S.), VIVUS,
Inc. (U.S.), Novo Nordisk A/S (Denmark), Orexigen Therapeutics, Inc. (U.S.), F.
Hoffmann-La Roche, Ltd. (Switzerland), Cousin Biotech (France), EnteroMedics,
Inc. (U.S.), Allergan (Republic of Ireland), Olympus Corporation (Japan),
Medtronic (U.S.), USGI Medical, Inc. (U.S.), Johnson & Johnson Services,
Inc. (U.S.), Covidien plc (Republic of Ireland), Mediflex Surgical Products
(U.S.), and others.
Obesity Treatment Market Regional Analysis
The Americas is slated to take the lead of the global market
during the forecast period by maintaining a steady flow of investment,
increasing awareness, and funding various research projects. The US and Canada
would impact the market the most. In Asia Pacific, the growth would experience
traction from rising disposable income.
Related Reports:
